Study of the Effect of the VR Technology on Recovery of the Autonomic Nervous System in Volunteers Affected by Stress

April 11, 2019 updated by: Pure Purr LLC

Randomized, Prospective, Sham-controlled, Blinded, Cross-over Clinical Study of the Effect of the Virtual Reality (VR) Technology on Recovery of Indicators of the Autonomic Nervous System in Healthy Volunteers Affected by Moderate Stress

The study assess the effect of the VR technology (Pure Purr technology) on the recovery of the autonomic nervous system in healthy volunteers affected by moderate stress. Study subject randomized into two groups: in Group 1 volunteers first be tested with the VR headset A, and during the next visit- headset B. Group 2 volunteers first be tested with the VR headset B, and during the next visit- headset A. Before, after and during VR session was conducted stress modulation and ECG recording.

The Pure Purr technology combines several audio and visual stimuli aimed at activation of the parasympathetic nervous system. Therefore, this study will investigate the effect of this technology on the recovery of autonomic nervous system performance after moderate stress.

Study Overview

Status

Completed

Conditions

Detailed Description

Pure Purr technology is based on discoveries in neurophysiology, medicine, acoustics, and computer engineering, which are used to initiate the physiological process of recreation, i.e. allostasis. Literally this term means "achieving stability through change". This is an active mechanism playing a part in normalization of the tone of the autonomic nervous system and maintaining stability of the body internal environment. The condition in which all our functions are implemented fully and sparingly in response to the load, and the level of adaptation remains high for a long time. Pure Purr is a software and hardware complex for relaxation and recreation based on a virtual reality headset with a display with sufficient resolution, built-in processor, memory, and extended-range stereo speakers. Positive effect on the cognitive function of the brain and the system of neurohumoral regulation is achieved due to the synchronous actuation of a number of stimuli, such as: visual sequence enhanced by the effect of virtual reality, harmonious music with the binaural rhythm technology, and modified cat purrs. Currently, the use of each technology is a scientifically proven trigger for the activation of individual parts of the human nervous system. And combining them in one software complex enhances the overall effect.

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kyiv Region
      • Kyiv, Kyiv Region, Ukraine
        • Doctor Sam Medical Network

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Females and males 20-60 years old;
  2. Volunteers have no history of cardiovascular diseases;
  3. Volunteers have no essential abnormalities on the ECG;
  4. Normal or moderate level of situational anxiety based on the Spielberger State-Trait Anxiety Inventory (STAI);
  5. Signed Informed Consent Form for participation in the study.

Exclusion Criteria:

  1. Intolerance to the VR technology;
  2. HR 110 bpm or below 50 bpm;
  3. RR above 23 breaths per minute;
  4. Abuse of alcohol, psychotropic substances and narcotic agents;
  5. Smoking more than 100 cigarettes a week;
  6. Administration of medicinal products for the treatment of cardiovascular and nervous system diseases 3 days prior to participation in the study;
  7. Drinking tonics and energy drinks for at least 2 hours prior to participation in the study;
  8. Severe or acute forms of respiratory, urogenital, gastrointestinal, haematological, metabolic, endocrine, or neurological diseases;
  9. Mental disorders, which, in the opinion of the investigator, may distort the results of the study;
  10. Participation in any clinical study over the last 3 months prior to enrolment to the study;
  11. Parkinson's disease, Parkinson's symptoms, tremor, restless leg syndrome, and other motility disorders;
  12. Pregnancy;
  13. Any disease of the thyroid gland.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Pure Purr VR technology

The arm will use the virtual reality headset reproduces a dynamic video content that is visually perceived with the help of the high-resolution screen.

The total length of the audio-video sequence is 6 minutes 11 seconds, of which 1 minute 11 seconds is the Pure Purr promotional video, and the duration of the investigational audio-visual sequence itself is 5 minutes.

The Pure Purr technology consists of BoboVR X1 headset with pre-installed software. The virtual reality headset reproduces a dynamic video content that is visually perceived with the help of the high-resolution screen. Also, the headset is able to play audio and transmit it via the headphones.

The audio sequence has been modified by adding a binaural effect and has been synchronized with the tact of respiratory movements and the frequency of heart rate.

Sham Comparator: Sham VR technology

The arm will use the headset with audio-visual sequence is similar to the one in the investigational version of the software. The key difference is that the audio sequence has not been modified with the binaural effect and has not been synchronized with the tact of respiratory movements and the frequency of heart rate.

The total length of the audio-video sequence is 6 minutes 11 seconds, of which 1 minute 11 seconds is the Pure Purr promotional video, and the duration of the investigational audio-visual sequence itself is 5 minutes.

The sham technology includes an identical BoboVR X1 virtual reality headset with pre-installed software. The audio-visual sequence is similar to the one in the investigational version of the software. The key difference is that the audio sequence has not been modified with the binaural effect and has not been synchronized with the tact of respiratory movements and the frequency of heart rate.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Power in high frequency range (HF) [ms2]
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from Power in high frequency range (HF) [ms2] at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The square root of the mean of the sum of the squares of differences between adjacent NN intervals (rMSSD), [ms]
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from rMSSD variable at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Standard deviation of all NN intervals (SDNN), [ms]
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from SDNN variable at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Ratio Power in low frequency range [ms2]/ Power in high frequency range [ms2] (Ratio LF [ms2]/HF [ms2])
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from Ratio LF [ms2]/HF [ms2] at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Total power (TP), [ms2]
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from Total power (TP) variable at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Heart Rate (HR) variable.
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from Heart Rate (HR) variable at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
BP (both systolic and diastolic blood pressure) variable.
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Change from systolic and diastolic blood pressure at 5 minutes before and after VR technology using
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days
Spielberger state-trait anxiety inventory (STAI) variable.
Time Frame: The outcome measure will be assessed between two visits with minimum interval 24 up to seven days

Change from STAI variable at 5 minutes before and after VR technology using. STAI-Examination of the level of situational anxiety.

Statement for еxamination:

  1. Calm down
  2. Safe
  3. Tense
  4. Annoyed
  5. Comfortable
  6. Upset
  7. Concerned with future misfortunes
  8. Relaxed
  9. Anguished
  10. At ease
  11. Self-confidence
  12. Nervous
  13. Restless
  14. Downhearted
  15. Rested
  16. Satisfied
  17. Concerned
  18. Stunned
  19. Happy
  20. I fell good

The range for each subscale from 1 to 4 point.

Processing of results:

Calculate the total score based on answers given by volunteers.

While interpreting the results, use the following levels of anxiety:

  • up to 30 points - low,
  • 31 - 44 points - moderate;
  • 45 and more - high.
The outcome measure will be assessed between two visits with minimum interval 24 up to seven days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Sam Aganov, Ph.D., Dr. Sam LLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2018

Primary Completion (Actual)

November 14, 2018

Study Completion (Actual)

November 14, 2018

Study Registration Dates

First Submitted

May 2, 2018

First Submitted That Met QC Criteria

May 21, 2018

First Posted (Actual)

May 22, 2018

Study Record Updates

Last Update Posted (Actual)

April 16, 2019

Last Update Submitted That Met QC Criteria

April 11, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PurePurr-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Pure Purr VR technology

3
Subscribe